ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

RGC vs TRLV // EV/EBITDA & P/E VALUATION

Regencell Bioscience Holdings Limited (NASDAQ) VS. Trulieve Cannabis Corp. Subordinate Voting Shares (NYSE) • 15-METRIC TALLY: RGC 1 — TRLV 3
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (RGC VS. TRLV) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC RGC TRLV SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 60.20% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) — 12.80% — TIE /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — 9.9x — TIE /valuation <GO>
Free Cash Flow Yield -0.10% 11.20% -11.30 TRLV /fcf-yield <GO>
Operating Margin — 12.10% — TIE /operating-margins <GO>
Net Profit Margin — -9.90% — TIE /net-margins <GO>
Revenue Growth (YoY) — -0.40% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 1.12 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 6/9 -4.00 TRLV /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 42.8 43.3 -0.49 TRLV /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $3.40B $2.04B $1.36B RGC /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR RGC REV TRLV REV RGC GROSS % TRLV GROSS % RGC FCF TRLV FCF
FY 2025 $0 $1.18B — 60.2% -$3.3M $228.6M
FY 2024 $0 $1.19B — 60.3% -$4.0M $148.9M
FY 2023 $0 $1.13B — — -$5.0M $201.8M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
RGC // BETA —
TRLV // BETA —